Inventurus Knowledge Solutions Limited, a leading technology-enabled healthcare solutions provider, has reported robust financial results for the first quarter of fiscal year 2026, along with significant changes to its board of directors.

Financial Highlights

For the quarter ended June 30, 2025, Inventurus Knowledge Solutions posted impressive growth:

• Consolidated revenue from operations increased by 15.6% year-over-year to ₹7,400.95 crore
• EBITDA grew by 36.3% year-over-year to ₹2,378.00 crore, with an EBITDA margin of 32.1%
• Profit After Tax (PAT) surged by 58.7% year-over-year to ₹1,515.39 crore
• Adjusted PAT rose by 51.4% year-over-year to ₹1,682.00 crore

The company's performance demonstrates strong momentum in its integrated tech-led care enablement platform, built on solid client relationships and disciplined execution.

Key Business Developments

Inventurus Knowledge Solutions expanded its reach through strategic partnerships:

• New collaboration with Mission Community Hospital for end-to-end revenue cycle management
• Partnership with Bicycle Health to manage revenue cycle and enable rapid growth of their virtual network
• Expanded relationship with OrthoNY to introduce IKS Virtual Clinical Assistant
• Extended partnership with a top 5 U.S. health system for coding services

Board Restructuring and Management Changes

The company announced several significant changes to its board and management structure, effective August 1, 2025:

1. Sachin Gupta, founder and current Whole-time Director, will transition to the role of Additional Director (Non-Executive, Non-Independent). He has been designated as Global CEO of Inventurus Knowledge Solutions Inc., USA, a wholly-owned subsidiary of the company.

2. Nithya Balasubramanian, the current Chief Financial Officer, has been appointed as an Additional Director (Whole-time Director) for a five-year term, subject to shareholder approval.

3. Dr. Garheng Albert Kong joins the board as an Additional Director (Non-Executive, Independent) for a five-year term, pending shareholder approval. Dr. Kong brings extensive experience in healthcare investment and innovation.

Internal Auditor Appointment

The board has reappointed M/s. KKC & Associates LLP, Chartered Accountants, as the Internal Auditor for the financial year 2025-26.

Sachin K. Gupta, Founder & Global CEO of IKS Health, commented on the results: "Our performance this quarter reflects the continued momentum in our business and the stickiness of our integrated tech-led care enablement platform. As we move forward, our focus remains on deepening client value, investing in innovation, and scaling our platform to address the evolving needs of the healthcare ecosystem."

Nithya Balasubramanian, CFO of IKS Health, added: "We delivered a strong financial performance in Q1 FY26, driven by consistent revenue growth and continued focus on operational efficiency. As we move ahead, we remain committed to sustaining healthy margins while strategically investing in capabilities that drive long-term value creation."

The board changes and strong financial results position Inventurus Knowledge Solutions for continued growth and innovation in the healthcare technology sector.

Inventurus Knowledge Solutions Limited (NSE: IKS) has reported strong financial results for the first quarter of fiscal year 2026, showcasing significant growth in both revenue and profitability.

Financial Highlights

The technology-enabled healthcare solutions provider announced a consolidated net profit of 1.52 billion rupees for Q1 FY26, marking a substantial 59% year-on-year increase from 955 million rupees in the same period last year. This impressive growth in profitability underscores the company's operational efficiency and strong market position.

Revenue for the quarter stood at 7.4 billion rupees, up 16% from 6.4 billion rupees in Q1 FY25. This robust top-line growth reflects the company's ability to expand its market share and capitalize on the growing demand for healthcare technology solutions.

Margin Improvement

Inventurus Knowledge Solutions demonstrated notable improvement in its profit margins. The company's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) margin expanded to 32.1% in Q1 FY26, up from 27.3% in the corresponding quarter of the previous year. This increase in EBITDA margin indicates enhanced operational efficiency and cost management.

Key Performance Metrics

Management Commentary

Sachin K. Gupta, Founder & Global CEO of IKS Health, commented on the results: "Our performance this quarter reflects the continued momentum in our business and the stickiness of our integrated tech-led care enablement platform built on strong client relationships, scalable solutions, and disciplined execution. The sustained revenue growth at 16% and improvement of EBITDA margin for the combined entity to 32% demonstrates the impact of our technology-led care enablement platform and global delivery capabilities."

Nithya Balasubramanian, CFO of IKS Health, added: "We delivered a strong financial performance in Q1 FY26, driven by consistent revenue growth and continued focus on operational efficiency. Our EBITDA margin improvement reflects disciplined cost management, scalability of our platform, and prudent capital allocation."

Business Highlights

The company reported several strategic partnerships and expansions during the quarter:

• New partnership with Mission Community Hospital for end-to-end revenue cycle management across hospital acute care and ambulatory surgery spaces.
• Collaboration with Bicycle Health to manage revenue cycle, enabling rapid growth and scale of their virtual network.
• Expanded partnership with OrthoNY to introduce IKS Virtual Clinical Assistant for administrative tasks and clinical efficiencies.
• Extended partnership with a top 5 U.S. health system for coding services to drive revenue performance and mitigate operational inefficiencies.

Corporate Developments

In addition to the financial results, Inventurus Knowledge Solutions announced several key corporate developments:

• Mr. Sachin Gupta has been designated as Global CEO of Inventurus Knowledge Solutions Inc, USA, a wholly-owned subsidiary of the company.
• Ms. Nithya Balasubramanian, the current CFO, has been appointed as an Additional Director (Whole-time Director) on the Board of the Company for a term of 5 years.
• Dr. Garheng Albert Kong has been appointed as an Additional Director (Non-Executive, Independent) on the Board of the Company for a term of 5 years.

These appointments are subject to shareholder approval and reflect the company's commitment to strengthening its leadership team and corporate governance.

As Inventurus Knowledge Solutions continues to expand its reach and impact in the healthcare technology sector, the strong Q1 FY26 results position the company for sustained growth and value creation in the coming quarters.